Significant Ownership of John C. Lipman
- Signature - Title
- /s/ John Lipman - John Lipman
- Location
- New York, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by John C. Lipman.
Follow Filing Activity
Follow John C. Lipman and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of John C. Lipman
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| USCTF | Roth CH Acquisition Co. | Class A Ordinary Shares, $0.0001 par value per share | 27% | $16,351,131 | 12,111,949 | John Lipman | 24 Jan 2025 | ||
| NDRA | ENDRA Life Sciences Inc. | Common Stock, par value $0.0001 | 10% | 115,477 | John Carter Lipman | 23 Oct 2025 | |||
| NEHC | NEW ERA HELIUM INC. | COMMON STOCK, PAR VALUE $0.0001 PER SHARE | 6.4% | $743,208 | 844,554 | John Lipman | 09 Dec 2024 |
Schedules 13D/G Reported by John C. Lipman:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.